HDAC5 (Histone Deacetylase 5) Protein

HDAC5 (histone deacetylase 5, encoded by the HDAC5 gene) is a class IIa histone deacetylase that regulates gene expression through chromatin modification and transcription factor interaction. It is highly expressed in the brain, where it plays critical roles in synaptic plasticity, memory formation, stress responses, and neuronal survival. HDAC5 is implicated in Alzheimer’s disease, Parkinson’s disease, depression, and stroke, making it a potential therapeutic target. ^{1The many roles of histone deacetylases in development and physiology: implications for heart disease, muscle disease, and cancer2009 · Nature Reviews Genetics · DOI 10.1038/nrg2516Open reference}

Gene and Protein Structure

flowchart TD
    HDAC5["HDAC5"] -->|"associated with"| STAT6["STAT6"]
    HDAC5["HDAC5"] -->|"involved in"| Tumor_Progression["Tumor Progression"]
    HDAC5["HDAC5"] -->|"drives"| tumor_progression["tumor progression"]
    HDAC5["HDAC5"] -->|"participates in"| epigenetic_regulation["epigenetic regulation"]
    HDAC5["HDAC5"] -->|"activates"| Cancer["Cancer"]
    HDAC5["HDAC5"] -->|"activates"| Carcinoma["Carcinoma"]
    HDAC5["HDAC5"] -->|"activates"| Tumor["Tumor"]
    HDAC5["HDAC5"] -->|"activates"| Als["Als"]
    HDAC5["HDAC5"] -->|"expressed in"| ALS["ALS"]
    HDAC5["HDAC5"] -->|"regulates"| STAT6["STAT6"]
    HDAC5["HDAC5"] -->|"activates"| STAT6["STAT6"]
    HDAC5["HDAC5"] -->|"activates"| SLC7A11["SLC7A11"]
    HDAC5["HDAC5"] -->|"activates"| TRIM28["TRIM28"]
    HDAC5["HDAC5"] -->|"phosphorylates"| TRIM28["TRIM28"]
    style HDAC5 fill:#4fc3f7,stroke:#333,color:#000

Structural Features

bfe67bb53c3c532ef4237fa3323691ae27404769

1. N-terminal regulatory domain: Contains binding sites for transcription factors (MEF2, HIC1, CtBP) and importin-alpha binding sites for nuclear-cytoplasmic shuttling. This region contains serine residues (Ser259, Ser498) that are phosphorylated by kinases such as CaMK and PKD

2. Catalytic deacetylase domain: Located in the C-terminal portion; retains the HD domain but has reduced catalytic activity compared to class I HDACs. The catalytic domain interacts with the N-terminal repressor domain to regulate gene expression

3. Nuclear localization signal (NLS): Situated near the N-terminus

4. Nuclear export signal (NES): Located in the C-terminal region

Class IIa Specificity

Class IIa HDACs (HDAC4, HDAC5, HDAC7, HDAC9) differ from class I HDACs (HDAC1-3, 8) in several ways:

• They have low intrinsic deacetylase activity and function primarily as transcriptional corepressors through recruitment of other proteins (e.g., NCoR/SMRT complexes, Sin3A)

• They shuttle between nucleus and cytoplasm in response to cellular signals (particularly calcium and cAMP)

• They have tissue-enriched expression patterns (HDAC5 is enriched in brain, heart, and skeletal muscle)

Normal Function

Chromatin Modification and Gene Regulation

HDAC5 exerts its transcriptional repression effects through multiple mechanisms:

1. Histone deacetylation: HDAC5 deacetylates histone H3 and H4 tails, creating a chromatin environment that suppresses transcription

2. Non-histone protein deacetylation: HDAC5 can deacetylate transcription factors (MEF2, p53, NF-κB) and other regulatory proteins

3. Corepressor complex recruitment: HDAC5 recruits NCoR/SMRT complexes and Sin3A to specific gene promoters

4. Interaction with HDAC3: HDAC5 forms complexes with class I HDAC3, which provides the actual deacetylase activity

Key Transcriptional Targets

Signal-Dependent Nuclear Export

HDAC5 is a central node in calcium and cAMP signaling to the nucleus:

1. Activation of CaMK: Synaptic activity and neurotransmitter signaling activate calcium/calmodulin-dependent kinase (CaMK)

2. Phosphorylation: CaMK (and PKD) phosphorylates HDAC5 at Ser259 and Ser498

3. 14-3-3 binding: Phosphorylated HDAC5 binds 14-3-3 proteins, which mask the NLS and expose the NES

4. Nuclear export: Exportin CRM1 binds the exposed NES and shuttles HDAC5 to the cytoplasm

5. Gene derepression: Removal of HDAC5 from chromatin allows activation of HDAC5-repressed genes

Roles in the Healthy Brain

In the healthy brain, HDAC5 regulates:

• Synaptic plasticity: Activity-dependent chromatin remodeling at synaptic plasticity genes (c-Fos, BDNF, Arc)

• Memory formation: Consolidation of long-term memory through epigenetic regulation of memory-related genes

• Neuronal development: Differentiation of neural progenitors and maturation of neurons

• Stress responses: Modulation of HPA axis activity and stress resilience

• Neurogenesis: Regulation of hippocampal neurogenesis

Role in Alzheimer’s Disease

HDAC5 is dysregulated in Alzheimer’s disease, with altered expression and localization in affected brains. ^{2Altered expression of HDAC5 in Alzheimer's disease brain2017 · Journal of Neuroscience Research · DOI 10.1002/jnr.24027Open reference}

Expression Changes in AD

• HDAC5 mRNA and protein levels are altered in AD brain tissue, particularly in the hippocampus and prefrontal cortex

• Altered subcellular localization (changes in nuclear/cytoplasmic ratio) have been reported in AD neurons

• The changes suggest both dysregulation of HDAC5 itself and disruption of the signaling pathways that control its localization

Synaptic Dysfunction

HDAC5 contributes to synaptic dysfunction in AD through:

• Activity-dependent gene dysregulation: Aβ oligomers disrupt calcium signaling, leading to abnormal HDAC5 nuclear export/retention and altered synaptic plasticity gene expression

• Memory consolidation deficits: HDAC5-mediated chromatin changes impair the formation of long-term memories

• Dendritic spine alterations: HDAC5 dysregulation affects spine morphology and density

Neuroprotection and Therapeutic Potential

• HDAC5 modulation: Altering HDAC5 activity or localization can protect neurons from Aβ toxicity

• Epigenetic therapy: HDAC5 is a target for HDAC inhibitor approaches in AD; Class I-selective HDAC inhibitors (entinostat) may spare HDAC5’s beneficial effects while achieving therapeutic benefit

• Interaction with tau: Some evidence suggests HDAC5 may interact with tau pathology pathways

Role in Depression and Psychiatric Disorders

HDAC5 is a key regulator of mood and stress responses. ^{3Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity2015 · Frontiers in Pharmacology · PMID 26433268Open reference}

Antidepressant Mechanisms

• Stress regulation: Chronic stress increases HDAC5 nuclear levels in the hippocampus; antidepressant treatments (SSRIs, ECT) promote HDAC5 phosphorylation and nuclear export, allowing derepression of antidepressant-responsive genes

• HPA axis modulation: HDAC5 regulates genes involved in the hypothalamic-pituitary-adrenal (HPA) axis

• Synaptic plasticity in depression: HDAC5-mediated chromatin remodeling affects synaptic plasticity genes that are dysregulated in depression

Preclinical Evidence

• HDAC5 knockout mice show altered stress responses and antidepressant-like phenotypes

• Viral-mediated HDAC5 overexpression in the hippocampus produces antidepressant effects

• Class IIa HDAC-selective compounds have been explored as potential antidepressants

Role in Stroke and Brain Injury

HDAC5 is implicated in neuronal damage following stroke and ischemia. ^{4HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage2020 · Journal of Cerebral Blood Flow and Metabolism · PMID 31696766Open reference}

Ischemic Brain Injury

• HDAC5 and HDAC4 form a complex with DREAM (downstream regulatory element antagonist modulator) that binds to the NCX3 gene promoter and epigenetically suppresses NCX3 (sodium-calcium exchanger 3) expression

• NCX3 is neuroprotective during ischemia; suppression of its expression by HDAC4/5-DREAM complexes exacerbates neuronal damage

• Pharmacological inhibition of this HDAC4/5-DREAM complex restores NCX3 expression and reduces stroke damage

Therapeutic Targeting in Stroke

• HDAC4/5-DREAM complex inhibitors: Small molecules targeting this repressive complex could restore neuroprotective gene expression

• Nuclear export-promoting agents: Compounds that promote HDAC5 phosphorylation and nuclear export could derepress protective genes

Role in Parkinson’s Disease

In Parkinson’s disease, HDAC5 may contribute to:

• Dysregulation of dopaminergic neuron survival pathways

• Alterations in stress response gene programs

• Potential cross-talk with alpha-synuclein pathology

Therapeutic Targeting

HDAC Inhibitors

HDAC inhibitors broadly target multiple HDAC enzymes. Key considerations for HDAC5:

Specific HDAC5 Modulators

• Developing selective HDAC5 modulators is challenging due to the structural similarity among class IIa HDACs

• Targeting HDAC5’s signal-dependent regulation (e.g., CaMK activators) may be more selective

• Protein-protein interaction disruptors targeting HDAC5’s repressor complexes

Challenges

• Isoform selectivity: Achieving selectivity for HDAC5 over HDAC4 and HDAC9 is difficult

• Brain penetration: Many HDAC inhibitors have limited CNS penetration

• Biphasic effects: HDAC5 has both protective and potentially harmful roles depending on context

• Nuclear vs. cytoplasmic function: Selective targeting of specific HDAC5 compartments may be needed

Protein Interactions

See Also

• HDAC5 Gene

• Alzheimer’s Disease

• Parkinson’s Disease

• Epigenetics in Neurodegeneration

• Synaptic Plasticity Pathways

• BDNF Protein

• HDAC Enzymes